Scott & Selber Inc’s DexCom DXCM Stock Holding History

Scott & Selber Inc’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14,268	Closed	-$1.47M	–	103
2020 Q3	$1.47M	Buy	14,268 +96	+0.7%	+$10K	0.66%	65
2020 Q2	$1.44M	Buy	+14,172	New	+$1.27M	0.71%	61

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Scott & Selber Inc's DXCM Position: Q4 2020 in Review

Scott & Selber Inc sold out of DexCom (DXCM) in Q4 2020, closing a stake of 14,268 shares — an estimated $1.47M sold.

Scott & Selber Inc first reported a position in DXCM in Q2 2020 and held it in 2 quarters. The position peaked at $1.47M in Q3 2020. 732 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

Scott & Selber Inc reported no remaining DexCom position as of Q4 2020 after selling out during the quarter.
Scott & Selber Inc sold 14,268 DexCom shares in Q4 2020, an estimated $1.47M.
Scott & Selber Inc first reported a position in DexCom in Q2 2020 and held it in 2 quarters.
Scott & Selber Inc's DexCom position peaked at $1.47M in Q3 2020.
732 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Scott & Selber Inc's 13F filing for Q4 2020, filed 4 Feb 2021.